Quality of prescribing for schizophrenia: Evidence from a national audit in England and Wales

Quality of prescribing for schizophrenia: Evidence from a national audit in England and Wales

Author: European Neuropsychopharmacology

National Audit of Schizophrenia (NAS) examined the quality of care received in England and Wales. Part of the audit set out to determine whether six prescribing standards, set by the national clinical guidelines for schizophrenia, were being implemented and to prompt improvements in care.

Cookie Settings